Keltie ranked as one of Europe’s top Patent Law Firms

Press release

With offices across the UK and Ireland, Keltie is one of the leading firms of IP specialists in Europe. The firm is internationally recognised by its peers across a number of core areas.

The firm has been ranked in both the Gold and Silver bands. Keltie’s 2023 four Gold and two Silver ratings are an improvement from their 2022 ranking.

Keltie is ranked Gold for:

Electrical Engineering & Physics
IT & Software
Biotechnology, Food & Healthcare
Mechanical Engineering

And Silver for:

Chemistry & Pharmaceuticals
Materials & Nanotechnology

Alan McFarlane, CEO of Keltie commented “I am delighted to see Keltie listed again as one of the leading Intellectual Property Firms in Europe. It is always encouraging to see external recognition of the quality of our work and the value of the services we provide across all areas of IP Management. Our team of high-quality attorneys, including internationally recognised Partners, is second to none, and fully deserving of these awards”.

Europe’s Leading Patent Law Firms 2023 Listings are based on recommendations made by clients and peers to FT research partner Statista

To see the full rankings, including their methodology and details of the research process, click here.

About Keltie

Keltie is renowned for its excellence, earned by putting talented, energetic, and principled people at its heart. Headquartered in London and with offices in Cambridge, the Cotswolds, and Ireland, Keltie specialises in IP law and management. Its clients benefit from experienced IP attorneys who work across all technologies and commercial fields.

Ends

Continue reading about Keltie ranked as one of Europe’s top Patent Law Firms

Alan McFarlane

About the author More from the author

01.05.2025

AI-Driven Materials Innovation: Protecting Breakthroughs in Computational Design

The fusion of Artificial Intelligence (AI) and materials science is changing how industries work, from energy and construction to advanced manufacturing. AI is speeding up discovery, from low-carbon cement to quantum-designed materials. To keep up, your IP strategy needs to evolve, too.

01.04.2025

Protecting Inventions while preserving biodiversity

Investing in biodiversity conservation and research is not just environmentally responsible—it's medically strategic, as each species lost represents the permanent erasure of unique biochemical compounds that could hold the key to treating current and future diseases. Understanding biodiversity also impacts diverse fields such as animal and plant breeding, agritech and public health.